ElleVet Sciences

ElleVet Sciences is a science-driven veterinary biotech company focused on the development of cannabinoid-based products for companion animals. Founded in 2017 and headquartered in Portland, Maine, the company is a leader in the pet CBD space, distinguished by its heavy investment in clinical research and evidence-based formulations. ElleVet gained prominence by conducting the first successful pharmacokinetic and efficacy clinical trial of CBD in dogs at Cornell University College of Veterinary Medicine. Their product portfolio includes proprietary CBD+CBDA oils, soft chews, and capsules specifically designed to manage pain, stress, and neurological conditions in dogs and cats. The company operates with a focus on high-quality manufacturing and rigorous testing to ensure safety and efficacy for the veterinary market.